Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher, above historical average.
Left:
||||
Free cash flow yield
Latest
4.07%
↑ 242% above average
Average (9y)
1.19%
Historical baseline
Range
High:4.07%
Low:-3.29%
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 4.07% | +44.7% |
| 2023 | 2.81% | -0.5% |
| 2022 | 2.82% | -2.5% |
| 2021 | 2.89% | +18.6% |
| 2020 | 2.44% | +81.5% |
| 2019 | 1.34% | +19.5% |
| 2018 | 1.12% | +175.8% |
| 2017 | -1.48% | +54.9% |
| 2016 | -3.29% | -294.1% |
| 2015 | -0.84% | - |